Abstract |
Fibrous papules of the face are hamartomas characterized by stellate-shaped stromal cells, multinucleated giant cells, and proliferative blood vessels in the dermis. The pathogenesis of fibrous papules remains unclear. There is a striking microscopic resemblance between fibrous papules and tuberous sclerosis complex ( TSC)-associated angiofibromas. A germline mutation of the TSC1 or TSC2 gene, leading to activation of the mammalian target of rapamycin (mTOR) pathway, accounts for the pathogenesis of TSC-associated angiofibromas. Activated mTOR subsequently activates p70 ribosomal protein S6 kinase ( p70S6K) and ribosomal protein S6 (S6) by phosphorylation. Rapamycin, a mTOR inhibitor, is effective in treating TSC-associated angiofibromas. The aim of this study was to understand whether the mTOR pathway is activated in fibrous papules. We studied immunoexpressions of phosphorylated (p-) mTOR effectors in fibrous papules, TSC-associated angiofibromas, and normal skin controls. P-mTOR, p-p70S6K and p-S6 were highly expressed in dermal stromal cells and epidermal keratinocytes in fibrous papules and TSC-associated angiofibromas but not in fibroblasts and epidermal keratinocytes of normal skin controls (p<0.001). The results suggest topical rapamycin may be a novel treatment option for fibrous papules.
|
Authors | Jung-Yi Lisa Chan, Kuo-Hsien Wang, Chia-Lang Fang, Wei-Yu Chen |
Journal | PloS one
(PLoS One)
Vol. 9
Issue 2
Pg. e89467
( 2014)
ISSN: 1932-6203 [Electronic] United States |
PMID | 24558502
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- TSC1 protein, human
- TSC2 protein, human
- Tuberous Sclerosis Complex 1 Protein
- Tuberous Sclerosis Complex 2 Protein
- Tumor Suppressor Proteins
- MTOR protein, human
- Ribosomal Protein S6 Kinases, 70-kDa
- TOR Serine-Threonine Kinases
|
Topics |
- Angiofibroma
(pathology)
- Enzyme Activation
- Face
(pathology)
- Hamartoma
(drug therapy, pathology)
- Humans
- Immunohistochemistry
- Ribosomal Protein S6 Kinases, 70-kDa
(metabolism)
- TOR Serine-Threonine Kinases
(metabolism)
- Tuberous Sclerosis
(pathology)
- Tuberous Sclerosis Complex 1 Protein
- Tuberous Sclerosis Complex 2 Protein
- Tumor Suppressor Proteins
(genetics)
|